Literature DB >> 6099644

Vaccinology of poliomyelitis.

D Salk, J Salk.   

Abstract

Vaccinology requires not only an understanding of the fundamental properties of the immune system and specific immunogens, but also the application of basic knowledge to develop effective immunization programmes for particular social, political, and environmental conditions. Two problems exist in the use of oral, live poliovirus vaccine: the occurrence of vaccine-associated paralytic poliomyelitis and the uncertain antibody response in tropical climates. These difficulties can be overcome by the use of killed poliovirus vaccine formulated to be effective with a single dose. Application of basic principles can bring poliomyelitis fully under control in all parts of the world.

Entities:  

Keywords:  Bacterial And Fungal Diseases; Biology; Communicable Disease Control; Communicable Diseases--prevention and control; Delivery Of Health Care; Diseases; Health; Health Services; Immunity; Immunization; Immunologic Factors; Infections; Medicine; Physiology; Preventive Medicine; Primary Health Care; Public Health; Vaccination; World

Mesh:

Substances:

Year:  1984        PMID: 6099644     DOI: 10.1016/s0264-410x(98)90035-4

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Ferretting out the facts behind the H5N1 controversy.

Authors:  Roy D Sleator
Journal:  Bioeng Bugs       Date:  2012-05-01

Review 2.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.

Authors:  Martin F Bachmann; Gary T Jennings
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

3.  Progress in genetics and genomics of nonhuman primates. Introduction.

Authors:  John D Harding
Journal:  ILAR J       Date:  2013

Review 4.  Tissue-based class control: the other side of tolerance.

Authors:  Polly Matzinger; Tirumalai Kamala
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

Review 5.  Drug delivery issues in vaccine development.

Authors:  M F Powell
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

Review 6.  Genomic Tools for the Use of Nonhuman Primates in Translational Research.

Authors:  John D Harding
Journal:  ILAR J       Date:  2017-07-01

7.  Immunisation practice and policy.

Authors:  D L Miller
Journal:  J Epidemiol Community Health       Date:  1984-12       Impact factor: 3.710

8.  Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine.

Authors:  A J Cann; G Stanway; P J Hughes; P D Minor; D M Evans; G C Schild; J W Almond
Journal:  Nucleic Acids Res       Date:  1984-10-25       Impact factor: 16.971

9.  Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals.

Authors:  Yvonne E Thomassen; Aart G van 't Oever; Monique G C T van Oijen; René H Wijffels; Leo A van der Pol; Wilfried A M Bakker
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

10.  Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV.

Authors:  Miriam E R Darnell; Kanta Subbarao; Stephen M Feinstone; Deborah R Taylor
Journal:  J Virol Methods       Date:  2004-10       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.